AdCella expands clinical advisory board
Filed with ASX · · 3 pages · English
Earlier from AdAlta
- AdCella Clinical Advisory Board convened
- Half Yearly Report and Accounts
- Quarterly Appendix 4C and Activities Report
- AdCella milestones and regulatory progress
- Placement raises A$1.2 million
Later from AdAlta
- New AD-214 patent granted
- AdCella and SHcell hold first JDC meeting
- BZDS1901 clinical update
- Automated cell therapy manufacturing MoU
- BZDS1901 manufacturing agreement
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta